Bruce Fernstrom, PA
Surgical · Portland, ORNPI 1255329967
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Intuitive Surgical at 54.8% of the total. Reporting peaked in 2023 at $1,223 and has fallen 76.1% since, to $292 in 2025.
Across 43 payments — averaging $45.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- AbbVie$325
- Sumitomo Pharma America, Inc.$114
- Accord Healthcare, Inc.$88
- Bayer$85
- Dendreon Pharmaceuticals LLC$45
- plus $233 from 9 others
What the payments were for
- Travel & lodging$1,07955%
- Food & beverage$85643%
- Education$352%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 3 | $1,079 |
| AbbVie | 17 | $325 |
| Sumitomo Pharma America, Inc. | 3 | $114 |
| Accord Healthcare, Inc. | 5 | $88 |
| Bayer | 3 | $85 |
| Dendreon Pharmaceuticals LLC | 2 | $45 |
| Teleflex LLC | 1 | $40 |
| AstraZeneca | 1 | $35 |
| Urogen Pharma, Inc. | 1 | $33 |
| Convatec Inc. | 1 | $28 |
| Coloplast | 2 | $27 |
| Immunitybio, Inc. | 1 | $21 |
| Merck | 1 | $19 |
| Astellas Pharma US Inc | 1 | $17 |
| Smith+Nephew | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,060
How this compares
$1,970 in reported general payments places this provider in the 85th percentile of 229 surgical providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 77 | $66,705 |
| MyrbetriqMirabegron | 58 | $65,355 |
| Tamsulosin Hcl | 445 | $7,093 |
| Finasteride | 343 | $4,594 |
| Trospium Chloride | 48 | $2,656 |
| Testosterone Cypionate | 33 | $1,547 |
| Potassium Citrate ErPotassium Citrate | 11 | $1,366 |
| Methenamine Hippurate | 15 | $1,322 |
| Solifenacin Succinate | 21 | $980 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 35 | $878 |
| Dutasteride | 30 | $871 |
| Cephalexin | 62 | $825 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 29 | $813 |
| NitrofurantoinNitrofurantoin Macrocrystal | 14 | $788 |
| Estradiol | 17 | $781 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $114 | $66,70577 claims |
| Astellas Pharma US IncMyrbetriq | $17 | $65,35558 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 229 surgical providers in Oregon.
Other surgical in Portland
- Justin ThibeaultPortland$6K
- Shea DeklotzPortland$5K
- Colleen PhillipsPortland$4K
- Michael PurvisPortland$4K
- Barry JacoshenkPortland$4K
- Carrie HayesPortland$3K
- Elizabeth MillerPortland$3K
- Callum MackintoshPortland$3K
- Mary PorterPortland$3K
- Audrey HyemPortland$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.